AI; R-CNNAI-Assisted Knee Ultrasound Analysis for Outcome Prediction in Degenerative Knee Disorders
This study observes how well an AI model identifies and segments normal knee structures, differentiates between normal and pathological knee structures, and predicts successful clinical outcomes after ultrasound-guided injection therapy in individuals with degenerative knee disorders.
Diagnostic Test Data
Collected from today forward - ProspectiveArthritis+3
+ Joint Diseases
+ Musculoskeletal Diseases
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Summary
Study start date: July 1, 2026
Actual date on which the first participant was enrolled.High-resolution musculoskeletal ultrasonography has become a first-line imaging modality because it enables real-time visualization and dynamic assessment with high accessibility and low cost. Nevertheless, ultrasound remains highly operator-dependent, resulting in variability in image acquisition and interpretation, which limits standardization and widespread implementation, particularly for complex joints such as the knee. Building on our established expertise in computational ultrasound and deep-learning-assisted dynamic shoulder analysis, including patented artificial intelligence (AI)-derived quantitative biomarkers, this three-year project aims to develop an AI platform for advanced knee ultrasound analysis and to construct a predictive model for clinical outcomes following ultrasound-guided injections in degenerative knee disorders. In the first year, we will establish a normative AI foundation model for knee ultrasonography by developing automated localization and multi-structure segmentation of major anatomical components, including tendons, ligaments, cartilage, fat pads, and peripheral nerves. Standardized acquisition protocols will be implemented to ensure consistent image quality. A Faster Region-Based Convolutional Neural Network (Faster R-CNN) framework incorporating ResNet50, a Feature Pyramid Network, and a Region Proposal Network will be used to detect key bony landmarks, followed by a multi-structure segmentation engine and quantitative feature extraction modules (e.g., thickness, surface regularity, and tissue heterogeneity). Segmentation performance will be evaluated using Intersection-over-Union and Dice coefficients, while measurement reliability will be assessed using intraclass correlation coefficients, standard error of measurement, minimal detectable change, and Bland-Altman analyses. In the second year, the platform will be expanded to differentiate pathological patterns in knee tendons, ligaments, cartilage, and fat pads. Expert clinicians will label each segmented structure as normal or abnormal and further annotate clinically relevant subtypes, such as tendinopathy, calcification, partial or full-thickness tears, synovial hypertrophy or effusion, cartilage wear or exposure, and meniscal degeneration or tear. Supervised learning models will be trained for classification and evaluated using accuracy, precision, recall (sensitivity), and F1-score. In the third year, we will develop an outcome prediction model for ultrasound-guided injections by integrating retrospective and prospective real-world data from approximately 150 patients receiving common injection therapies, including intra-articular hyaluronic acid, dextrose prolotherapy or platelet-rich plasma, and peripheral nerve-targeted interventions. Treatment success will be defined using validated patient-reported outcome measures, including the Knee Injury and Osteoarthritis Outcome Score and the Patient Acceptable Symptom State, incorporating minimal clinically important difference thresholds. Feature selection methods and cross-validation will be applied to mitigate overfitting. Model performance will be assessed using area under the receiver operating characteristic curve, sensitivity, specificity, accuracy, F1-score, and calibration metrics, with Shapley Additive exPlanations employed to enhance interpretability. External validation will be performed if additional datasets become available. This project is expected to deliver the first systematic AI-based normative atlas for knee ultrasonography and an interpretable outcome prediction framework, improving diagnostic consistency, reducing operator dependency, and enabling personalized, evidence-informed injection strategies.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.310 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Objective 1: Development of an AI-Based Normative Model for the Healthy Knee Inclusion Criteria: * Clinical diagnosis of healthy adult without major systemic disease * Age ≥18 years * Able to understand and follow study instructions * Ambulatory without walking aids * No pain in either knee for at least 6 months before enrollment Exclusion Criteria: * Previous knee surgery * Rupture of one or more cruciate ligaments * Knee injection within the preceding 6 months * Major trauma involving the knee or periarticular region * Rheumatic or autoimmune disease Objective 2: Development of an AI-Based Model for the Identification of Pathological Knee Structures Inclusion Criteria: * Clinical diagnosis of radiographic knee osteoarthritis * Age ≥18 years * Knee pain in at least one knee during the preceding year * Medical records confirming knee pain, soreness, or stiffness within 1 month before enrollment * Radiographic evidence of knee osteoarthritis, defined by at least one of the following: * Kellgren-Lawrence grade ≥2 on anteroposterior radiographs * Kellgren-Lawrence grade ≥2 on skyline (patellofemoral) radiographs * Superior or inferior patellar osteophytes or posterior tibial osteophytes on lateral radiographs Exclusion Criteria: * Systemic rheumatic disease (e.g., rheumatoid arthritis or ankylosing spondylitis) * Malignancy * Previous major knee trauma (including fracture) * Previous knee surgery * Intra-articular corticosteroid injection within the preceding 3 months Objective 3: Development of an AI-Assisted Predictive Model for Injection Treatment Outcomes Inclusion Criteria: * Clinical diagnosis of radiographic knee osteoarthritis requiring ultrasound-guided injection therapy * Age ≥18 years * Knee pain in at least one knee during the preceding year * Medical records confirming knee pain, soreness, or stiffness within 1 month before enrollment * Radiographic evidence of knee osteoarthritis, defined by at least one of the following: * Kellgren-Lawrence grade ≥2 on anteroposterior radiographs * Kellgren-Lawrence grade ≥2 on skyline (patellofemoral) radiographs * Superior or inferior patellar osteophytes or posterior tibial osteophytes on lateral radiographs * Willingness to undergo ultrasound-guided injection therapy and complete scheduled follow-up assessments Exclusion Criteria: * Systemic rheumatic disease (e.g., rheumatoid arthritis or ankylosing spondylitis) * Malignancy * Previous major knee trauma (including fracture) * Previous knee surgery * Intra-articular corticosteroid injection within the preceding 3 months
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
National Taiwan University Hospital Beihu Branch
Taipei, TaiwanOpen National Taiwan University Hospital Beihu Branch in Google Maps